Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (376)	4/5/1999 2:06:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 550

David, can you pull a handful of stocks of your valuation list which have anti- angiogenesis compounds. I know there must be a few less well-known companies, which are also bargains in which to invest. We have seen good discussion of Celgene by the biotech guys...I believe ImClone has a candidate, preclinical, and then there is angiopoietins/TIE receptor but I have read those posts and it is of course over my head. Cheap biotech stocks all over, but cant own them all! Also there are crazy gambles like Magainin, of which I was again reminded on another thread--maybe that one has bottomed out too, but I can not say anything at all about any of the science. Was disappointed by the Waldholz interview, small/micro biotech is really ignored, MW did not do much to get anybody excited, he must be trading internuts with the rest of them...